Key facts
- This page summarizes ModernaTX, Inc.'s Form 3 filing for Carisma Therapeutics Inc. (CARM).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Mar 2023, 17:06.
ModernaTX, Inc. - 07 Mar 2023 Form 3 Insider Report for Carisma Therapeutics Inc. (CARM)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CARM
- Reported as of
- 07 Mar 2023
- Net transaction value
- $0
- Reporting owner signature
- Brian Sandstrom, Assistant Secretary
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
ModernaTX, Inc. filed Form 3 for Carisma Therapeutics Inc. (CARM) on 13 Mar 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CARM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,059,338
- Date
- 07 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Pursuant to a reverse-merger transaction consummated on March 7, 2023, the Reporting Person became the beneficial owner of 12.57% of the Issuer's total shares outstanding.